A recent study suggests that patients who stop using new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise programs.
Published data in a prominent health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month after stopping.
"Individuals buying such medications must be informed of the danger of fast weight regain when the medication ends," warns researcher Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original weight in about one and a half years.
Comparing Approaches
The analysis, which examined dozens of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with older methods.
The team point out that individuals who shed pounds through lifestyle changes alone typically have a more gradual weight regain—around 100 grams monthly—once they finish.
The Reason for the Fast Regain
Experts propose the mechanism of the drugs explains the accelerated weight return.
GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating a significant risk."
A Chronic Disease?
The NHS advise the jabs for people with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians say that, considering the likelihood of weight regain, the treatment might need to be ongoing.
This opinion is reinforced by drug manufacturers, who say that the findings "underscore the long-term nature of excess weight," akin to managing conditions like high blood pressure.
Patient Accounts
Individuals who have stopped the medication describe a intense resurgence of appetite.
"It was like a switch activating and you're instantly extremely hungry," said one woman.
This challenge is exacerbated if patients have not adopted sustainable lifestyle or habit modifications during therapy.
Widespread Use
Figures suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than public health services.
In conclusion, experts stress that while these medications are powerful tools for weight loss, they are not a magic solution and lasting health benefits likely depends on integrated lifestyle management.
